While it is true that kratom is a plant, this fact does not inherently make it safe for consumption or free from regulatory oversight. Many plants, such as tobacco and opium poppies, produce compounds that can have significant, and often harmful, effects on human health. Kratom contains active alkaloids, such as mitragynine and 7-hydroxymitragynine, which have potent psychoactive and opioid-like properties. These compounds can lead to addiction, dependence, and severe health consequences, much like synthetic drugs.

Furthermore, the natural origin of kratom does not exempt it from the need for rigorous scientific evaluation and regulation. The lack of standardized dosing, potential for contamination, and inconsistent product quality in the unregulated market all pose significant risks to consumers. Ensuring public safety requires that all substances, whether natural or synthetic, undergo thorough testing to determine their safety, efficacy, and potential for abuse. Therefore, classifying kratom as a Schedule I controlled substance is a necessary step to protect public health and regulate its use appropriately.